Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: Report of 12 cases and review

Diagnostic Microbiology and Infectious Disease

Volumn 35, Issue 1, 1999, Pages 75-80

  Krcmery Jr V ^d,e   Filka, J ^a   Uher, J ^a   Kurak, H ^a   Sagat T ^b   Tuharsky J ^b   Novak I ^b   Urbanova T ^b   Kralinsky K ^c   Mateicka F ^d   Krcmeryova T ^b   Jurga, L' ^d   Sulcova M ^d   Stencl J ^c   Krupova I ^c  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b Dept of Paediatric Intensive Care ^*  (Slovakia)

^c Fakultna nemocnica s poliklinikou FD Roosevelta Banska Bystrica   (Slovakia)

^d TRNAVA UNIVERSITY   (Slovakia)

^e Heydukova 10   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CEFPIROME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; OFLOXACIN; PEFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PRIORITY JOURNAL; SEPSIS; SYMPTOMATOLOGY;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; MENINGITIS, BACTERIAL;

EID: 0033200176     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00052-8     Document Type: Article

References (21)

1. Aujard Y (1992) Quinolones in neonates. In Adam D, Rubio T: The use of quinolones in paediatric medicine. Fortschr Antimicrob Chemoth (Munich) 11-2; pp. 233-237.
2. Bannon M.J., Shutchfield P.R., Weindling A.M. Ciprofloxacin in Enterobacter cloacae septicaemia. Arch Dis Child. 64:1989;1388-1391.
3. Belobovodova NV, Birggarkov AV, Kurchavov, VA (1994) Clinical and bacteriological experience with ciprofloxacin in neonates. Abstracts-5-th Symposium on New Quinolones, Singapore, 28.-30.8. 1994, Ed. E. Rubinstein, Abstract N 129.
4. Bethell D.B., Hien T.T., Phi L.T. Effects on growth of single short courses of fluroquinolones. Arch Dis Child. 74:1996;44-46.
5. Black A., Redmont A.O.B., Steen H.J., Oborska I.T. Tolerance and safety of ciprofloxacin in pediatric patients. J Antimicrob Chemoth. 26:(suppl. F):1990;25-29.
6. Burkhardt J., Walterspiel J., Schaad U.B. Quinolone arthropathy in animals versus children. Clin Infect Dis. 25:1997;1196-1204.
7. Chysky V., Kapila K., Hullman R., Arciery G., Schacht P., Echols R. Safety of ciprofloxacin in children Worldwide clinical experience based on compassionate use. Emphasis on joint evaluation . Infections. 19:1991;289-296.
8. Cruciani M., Concia E., Navarra A. Prophylactic cotrimoxazole versus norfloxacin in neutropenic children - prospective randomized study. Infection. 17:1989;65-69.
9. Dagan R, Schlaufher F (1990) Parenteral fluoroquinolones in children with life threatening infections. Proceeding - 2nd Sym. on new quinolones (Geneva 1988), Rev Inf Dis 1990, 10, 1, Abstract. 136.
10. Danisovicova A., Brezina M., Belan S., Krcmery V. Jr. Magnetic resonance imaging in children receiving quinolones no evidence of quinolone induced arthropathy . Chemotherapy. 40:1994;209-214.
11. Gilbert D, Moellering KC, Sande M (1998) Cerebrospinal fluid concentrations of antimicrobials. In: Sanford J: Guide to antimicrobial therapy, Antimicrobial Therapy Inc., Vienna, 28-Ed., 58-59.
12. Hampel B., Hullmann R., Schmidt K. Ciprofloxacin in pediatrics, worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J. 16:1997;127-129.
13. Humphrey B., Sanders G., Marviak J. Flavobacterium odoratum sepsis in neonate treated with ciprofloxacin. Arch Dis Child. 64:1989;1119-1120.
14. Isaacs D., Slach M.P.E., Wilkinsu A.R., Westwood A.W. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antimicrob Chemoth. 17:1986;535-538.
15. Ragnnathan P.L., Potkins D.V., Watson J.G. Neonatal meningitis due to S. typhimurium treated with ciprofloxacin. J Antimicrob Chemoth. 26:1990;727.
16. Rubio T.T. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis. Diagn Microbiol Infect Dis. 13:1990;153-155.
17. Schaad U.B., Salam M.A., Aujard Y. Use of fluoroquinolones in pediatrics Consensus report of an international society of chemotherapy commission . Pediatr Infect Dis J. 14:(suppl. 1):1995;1-9.
18. Schaad U.B., Sander E., Wedgwood J., Schaffner T. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J. 11:1992;1047-1049.
19. Scully B.E., Nakatomi M., Ores C., Davidson S., Neu H.C. Ciprofloxacin therapy in cystic fibrosis. Am J Med. 82:(suppl. 4A):1987;196-201.
20. Segev S., Barzilai A., Roseu N., Joseph G., Rubinstein E. Pefloxacin treatment of meningitis caused by gramnegative bacteria. Arch Int Med. 149:1989;1314-1316.
21. Segev S., Roseu N., Joseph G., Elvan M.A., Rubinstein E. Pefloxacin efficacy in gramnegative bacillary meningitis. J Antimicrobial Chem. 26:1990;187-192.